Verona Pharma PLC (VRNA)
38.47
-0.38
(-0.98%)
USD |
NASDAQ |
Nov 21, 14:18
Verona Pharma Price: 38.47 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 38.00 | 39.33 | 37.61 | 38.85 | 1.156M |
Nov 19, 2024 | 35.49 | 38.30 | 34.97 | 38.09 | 1.440M |
Nov 18, 2024 | 35.52 | 36.10 | 34.51 | 34.94 | 1.119M |
Nov 15, 2024 | 35.01 | 35.96 | 34.71 | 35.66 | 988179.0 |
Nov 14, 2024 | 37.49 | 37.49 | 34.95 | 35.37 | 1.032M |
Nov 13, 2024 | 39.00 | 39.50 | 36.84 | 36.93 | 823285.0 |
Nov 12, 2024 | 39.35 | 40.13 | 38.78 | 39.00 | 1.604M |
Nov 11, 2024 | 38.97 | 40.02 | 38.73 | 39.87 | 1.488M |
Nov 08, 2024 | 38.50 | 38.87 | 37.52 | 38.58 | 1.196M |
Nov 07, 2024 | 37.54 | 38.25 | 36.48 | 38.18 | 623804.0 |
Nov 06, 2024 | 38.39 | 38.56 | 36.74 | 37.59 | 1.019M |
Nov 05, 2024 | 39.05 | 39.40 | 37.80 | 38.39 | 1.213M |
Nov 04, 2024 | 33.55 | 39.38 | 31.60 | 38.15 | 3.326M |
Nov 01, 2024 | 34.42 | 35.09 | 34.01 | 34.98 | 891626.0 |
Oct 31, 2024 | 34.00 | 34.33 | 33.31 | 33.93 | 641870.0 |
Oct 30, 2024 | 33.09 | 34.77 | 33.09 | 34.19 | 1.373M |
Oct 29, 2024 | 33.02 | 33.87 | 32.90 | 33.67 | 423272.0 |
Oct 28, 2024 | 34.00 | 34.25 | 33.03 | 33.11 | 549266.0 |
Oct 25, 2024 | 34.40 | 35.08 | 33.57 | 33.86 | 822214.0 |
Oct 24, 2024 | 34.87 | 35.20 | 34.38 | 34.43 | 615019.0 |
Oct 23, 2024 | 34.53 | 35.04 | 34.26 | 34.93 | 793643.0 |
Oct 22, 2024 | 34.53 | 35.62 | 34.23 | 34.87 | 1.104M |
Oct 21, 2024 | 34.56 | 35.25 | 34.25 | 34.97 | 1.197M |
Oct 18, 2024 | 34.65 | 35.28 | 34.33 | 34.63 | 994679.0 |
Oct 17, 2024 | 33.97 | 34.72 | 33.67 | 34.66 | 740542.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.16
Minimum
Mar 18 2020
39.87
Maximum
Nov 11 2024
11.87
Average
8.26
Median
Aug 20 2020
Price Benchmarks
Biodexa Pharmaceuticals PLC | 4.43 |
TC BioPharm (Holdings) PLC | 0.6326 |
Adaptimmune Therapeutics PLC | 0.6432 |
NuCana PLC | 1.28 |
Autolus Therapeutics PLC | 2.785 |
Price Related Metrics
PEG Ratio | -0.0748 |
Price to Book Value | 24.12 |
Earnings Yield | -5.20% |
Market Cap | 3.148B |
PEGY Ratio | -0.0748 |